Clinical trial
[14C]TGRX-678 Mass Balance Study in Chinese Healthy Male Adults
NCT06986772 is registered in ClinicalTrials.gov with Shenzhen TargetRx Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- [14C]TGRX-678 Mass Balance Study in Chinese Healthy Male Adults
- Lead sponsor
- Shenzhen TargetRx Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 7, 2025
- Completion date
- August 25, 2025
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myeloid leukemia